Immunisation against plague by transcutaneous and intradermal application of subunit antigens

Vaccine

Volumn 22, Issue 31-32, 2004, Pages 4365-4373

  Eyles, J E ^a   Elvin, S J ^a   Westwood, A ^a   LeButt, C S ^a   Alpar, H O ^b   Somavarapu, S ^b   Williamson, E D ^a  

^a Biomedical Sciences   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Enterotoxin; Immunisation; Mucosal; Non invasive; Skin; Subunit vaccines

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; CHOLERA TOXIN; ENTEROTOXIN; INTERLEUKIN 6; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN FRACTION 1; RECOMBINANT PROTEIN V; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; PROTEIN SECRETION; SPLEEN; SPLEEN CELL; YERSINIA PESTIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; CELL SEPARATION; CHOLERA TOXIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INJECTIONS, INTRADERMAL; INTERFERON TYPE II; INTERLEUKIN-5; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; SPLEEN; VACCINES, SYNTHETIC;

EID: 4944234407     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.02.049     Document Type: Article

References (24)

1. R.D. Perry, and J.D. Fetherston Yersinia pestis - etiologic agent of plague Clin. Microbiol. Rev. 10 1 1997 35 66
2. R.W. Titball, and E.D. Williamson Vaccination against bubonic and pneumonic plague Vaccine 19 30 2001 4175 4184
3. E.D. Williamson, S.M. Eley, and K.F. Griffin A new improved subunit vaccine for plague - the basis of protection FEMS Immunol. Med. Microbiol. 12 3-4 1995 223 230
4. R.W. Titball, and S.E.C. Leary Plague Br. Med. Bull. 54 3 1998 625 633
5. R.A. Smego, J. Frean, and H.J. Koornhof Yersiniosis I. Microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections Eur. J. Clin. Microbiol. Infect. Dis. 18 1 1999 1 15
6. E.D. Williamson, and R.W. Titball Vaccines against dangerous pathogens Br. Med. Bull. 62 2002 163 173
7. E.D. Williamson Plague vaccine research and development J. Appl. Microbiol. 91 4 2001 606 608
8. J.E. Eyles, E.D. Williamson, I.D. Spiers, and H.O. Alpar Protection studies following bronchopulmonary and intramuscular immunisation with Yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy Vaccine 18 28 2000 3266 3271
9. J.E. Eyles, I.D. Spiers, E.D. Williamson, and H.O. Alpar Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines Vaccine 16 20 1998 2000 2009
10. J.E. Eyles, G.J.E. Sharp, E.D. Williamson, I.D. Spiers, and H.O. Alpar Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse Vaccine 16 7 1998 698 707
11. G.M. Glenn, D.N. Taylor, X.R. Li, S. Frankel, A. Montemarano, and C.R. Alving Transcutaneous immunisation: a human vaccine delivery strategy using a patch Nat. Med. 6 12 2000 1403 1406
12. R.W. Titball, A.M. Howells, P.C.F. Oyston, and E.D. Williamson Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague Infect. Immun. 65 5 1997 1926 1930
13. E.D. Williamson, S.M. Eley, A.J. Stagg, M. Green, P. Russell, and R.W. Titball A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague Vaccine 15 10 1997 1079 1084
14. J.E. Eyles, V.W. Bramwell, E.D. Williamson, and H.O. Alpar Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration Vaccine 19 32 2001 4732 4742
15. J.W. Simecka, R.J. Jackson, H. Kiyono, and J.R. McGhee Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract Infect. Immun. 68 2 2000 672 679
16. H.P. Jones, L.M. Hodge, K. Fujihashi, H. Kiyono, J.R. McGhee, and J.W. Simecka The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunisation with antigen alone, but Th1 responses are induced during instances of intense immune stimulation J. Immunol. 167 8 2001 4518 4526
17. A.S. Beignon, J.P. Briand, S. Muller, and C.D. Partidos Immunisation onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge Immunology 102 3 2001 344 351
18. T. Scharton-Kersten, J.M. Yu, R. Vassell, D. O'Hagan, C.R. Alving, and G.M. Glenn Transcutaneous immunisation with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants Infect. Immun. 68 9 2000 5306 5313
19. S.A. Hammond, D. Walwender, C.R. Alving, and G.M. Glenn Transcutaneous immunisation: T cell responses and boosting of existing immunity Vaccine 19 17-19 2001 2701 2707
20. S. Babiuk, M. Baca-Estrada, L.A. Babiuk, C. Ewen, and M. Foldvari Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery J. Control. Release 66 2-3 2000 199 214
21. N. Puri, E.H. Weyand, S.M. Abdel-Rahman, and P.J. Sinko An investigation of the intradermal route as an effective means of immunisation for microparticulate vaccine delivery systems Vaccine 18 23 2000 2600 2612
22. J. Chin, F. SanGil, and M. Novak Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants J. Biotechnol. 44 1-3 1996 13 19
23. D.X. Chen, R.L. Endres, and C.A. Erickson Epidermal immunisation by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice Nat. Med. 6 10 2000 1187 1190
24. J.A. Mikszta, J.B. Alarcon, J.M. Brittingham, D.E. Sutter, R.J. Pettis, and N.G. Harvey Improved genetic immunisation via micromechanical disruption of skin-barrier function and targeted epidermal delivery Nat. Med. 8 4 2002 415 419